| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.733 | 104.176 | 97.924 | 236.063 | 150.315 | 188.049 | 145.047 |
| Total Income - EUR | - | - | - | 9.733 | 104.211 | 97.693 | 239.540 | 152.038 | 188.844 | 146.050 |
| Total Expenses - EUR | - | - | - | 4.120 | 68.593 | 57.608 | 194.027 | 122.353 | 144.287 | 119.473 |
| Gross Profit/Loss - EUR | - | - | - | 5.613 | 35.619 | 40.085 | 45.513 | 29.685 | 44.558 | 26.576 |
| Net Profit/Loss - EUR | - | - | - | 5.321 | 32.494 | 38.393 | 43.000 | 28.182 | 42.677 | 22.955 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Total Biotek S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.021 | 869 | 17.198 | 33.548 | 29.273 | 30.416 | 24.665 |
| Current Assets | - | - | - | 7.677 | 44.255 | 61.486 | 94.609 | 113.619 | 113.333 | 128.337 |
| Inventories | - | - | - | 0 | 2.547 | 4.172 | 9.048 | 12.001 | 13.640 | 5.984 |
| Receivables | - | - | - | 806 | 29.581 | 24.191 | 52.940 | 86.156 | 8.024 | 9.898 |
| Cash | - | - | - | 6.870 | 12.127 | 33.123 | 32.621 | 15.461 | 91.668 | 112.455 |
| Shareholders Funds | - | - | - | 5.536 | 32.746 | 70.519 | 107.912 | 28.425 | 42.920 | 59.925 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 3.232 | 12.378 | 8.165 | 20.245 | 114.467 | 103.903 | 96.134 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Total Biotek S.r.l.